43 results
424B3
EVOK
Evoke Pharma Inc
14 Mar 24
Prospectus supplement
6:44pm
party if Gimoti is subject to a safety recall; if the other party is in breach of certain regulatory compliance representations under the agreement … to maintain cGMP compliance.
Once an approval is granted, FDA may suspend, restrict or withdraw the approval, require a product recall, or impose additional
8-K
EX-1.1
EVOK
Evoke Pharma Inc
9 Feb 24
Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million
5:15pm
of, or the labeling and promotion of any FDA Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders … or issued, any recall, market withdrawal or replacement, safety alert, post-sale warning, “dear doctor” letter, or other notice or action relating
8-K
EX-1.1
yaih ku0jmhhwf
14 Jan 21
Evoke Pharma Announces Proposed Public Offering of Common Stock
5:22pm